DE60239622D1 - Verfahren zur diagnose oder überwachung eines fehlers im zuckerstoffwechsel - Google Patents
Verfahren zur diagnose oder überwachung eines fehlers im zuckerstoffwechselInfo
- Publication number
- DE60239622D1 DE60239622D1 DE60239622T DE60239622T DE60239622D1 DE 60239622 D1 DE60239622 D1 DE 60239622D1 DE 60239622 T DE60239622 T DE 60239622T DE 60239622 T DE60239622 T DE 60239622T DE 60239622 D1 DE60239622 D1 DE 60239622D1
- Authority
- DE
- Germany
- Prior art keywords
- monitoring
- substitute
- diagnosis
- sugar change
- gbp28
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 3
- 238000012544 monitoring process Methods 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title 1
- 102100031786 Adiponectin Human genes 0.000 abstract 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 3
- 108010076365 Adiponectin Proteins 0.000 abstract 1
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001248047 | 2001-08-17 | ||
| PCT/JP2002/008331 WO2003016906A1 (fr) | 2001-08-17 | 2002-08-16 | Procede de diagnostic ou de controle d'une erreur du metabolisme du saccharose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60239622D1 true DE60239622D1 (de) | 2011-05-12 |
Family
ID=19077272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60239622T Expired - Lifetime DE60239622D1 (de) | 2001-08-17 | 2002-08-16 | Verfahren zur diagnose oder überwachung eines fehlers im zuckerstoffwechsel |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7067634B2 (de) |
| EP (1) | EP1426764B1 (de) |
| JP (1) | JP3624216B2 (de) |
| AT (1) | ATE504001T1 (de) |
| AU (1) | AU2002328630B2 (de) |
| CA (1) | CA2459489C (de) |
| DE (1) | DE60239622D1 (de) |
| DK (1) | DK1426764T3 (de) |
| ES (1) | ES2361663T3 (de) |
| WO (1) | WO2003016906A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004086040A1 (ja) | 2003-03-24 | 2004-10-07 | Mitsubishi Kagaku Iatron, Inc. | アディポネクチン分析用ラテックス試薬及びアディポネクチン分析方法 |
| US20060286035A1 (en) * | 2003-04-29 | 2006-12-21 | Cytos Biotechnology Ag | Methods and compositions for modulating the interaction between adiponectin and its receptor |
| US7648825B2 (en) | 2003-06-20 | 2010-01-19 | University Of Florida Research Foundation, Inc. | Biomarkers for differentiating between type 1 and type 2 diabetes |
| US7176292B2 (en) * | 2003-09-11 | 2007-02-13 | Dialean, Ltd. | Ghrelin variant protein |
| US7781171B2 (en) | 2003-10-15 | 2010-08-24 | Daiichi Pure Chemicals Co., Ltd. | Mehod of pretreating sample and immunological assay method using the same |
| ATE439590T1 (de) * | 2003-10-15 | 2009-08-15 | Sekisui Medical Co Ltd | Verfahren zum selektiven testen von adiponectinmultimeren |
| EP1684807B1 (de) * | 2003-11-07 | 2009-09-02 | Merck & Co., Inc. | Verfahren zur identifizierung von respondern auf die behandlung mti insulinsensibilisatoren |
| WO2005092367A1 (ja) * | 2004-03-29 | 2005-10-06 | Fuji Oil Company, Limited | アディポネクチン分泌促進組成物 |
| US20080139468A1 (en) | 2004-03-31 | 2008-06-12 | Kazuhisa Maeda | Method For Control of Invasion and Use of Adiponectin |
| US8563581B2 (en) | 2005-02-02 | 2013-10-22 | Mitos Pharmaceuticals, Inc. | Nitroxides for use in treating predisposed or at risk patients |
| GB0617429D0 (en) * | 2006-09-05 | 2006-10-18 | Electrophoretics Ltd | Markers of renal transplant rejection and renal damage |
| ES2699627T3 (es) * | 2007-11-30 | 2019-02-12 | Siemens Healthcare Diagnostics Inc | Fragmentos de receptores de adiponectina y métodos de uso |
| WO2010123720A1 (en) | 2009-04-23 | 2010-10-28 | Siemens Healthcare Diagnostics Inc. | Monomeric and dimeric forms of adiponectin receptor fragments and methods of use |
| AU2010245543B2 (en) | 2009-05-07 | 2015-08-13 | Otsuka Pharmaceutical Co., Ltd. | Novel monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same |
| JP5048100B2 (ja) | 2010-04-28 | 2012-10-17 | シャープ株式会社 | アディポネクチンに対する結合性を有するペプチド、ならびに該ペプチドを用いた分析方法および分析装置 |
| RU2553943C1 (ru) * | 2014-05-27 | 2015-06-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения Российской Федерации (ГБОУ ВПО МГМУ им. И.М. Сеченова) | Способ диагностики инсулинорезистентности |
| EP3903105A1 (de) * | 2019-02-18 | 2021-11-03 | The University Of Liverpool | Diagnoseverfahren |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE98950411T1 (de) | 1997-10-29 | 2005-10-20 | Otsuka Pharma Co Ltd | Zusammensetzung zur Inhibierung der Proliferation glatter Muskulatur, Verfahren zur Diagnose von Arteriosklerose, sowie Kits hierzu |
| WO2001032868A1 (en) | 1999-11-04 | 2001-05-10 | Genset | Apm1 biallelic markers and uses thereof |
-
2002
- 2002-08-16 JP JP2003521362A patent/JP3624216B2/ja not_active Expired - Lifetime
- 2002-08-16 US US10/487,039 patent/US7067634B2/en not_active Expired - Lifetime
- 2002-08-16 CA CA002459489A patent/CA2459489C/en not_active Expired - Fee Related
- 2002-08-16 EP EP02762796A patent/EP1426764B1/de not_active Expired - Lifetime
- 2002-08-16 DK DK02762796.7T patent/DK1426764T3/da active
- 2002-08-16 AT AT02762796T patent/ATE504001T1/de not_active IP Right Cessation
- 2002-08-16 ES ES02762796T patent/ES2361663T3/es not_active Expired - Lifetime
- 2002-08-16 AU AU2002328630A patent/AU2002328630B2/en not_active Ceased
- 2002-08-16 DE DE60239622T patent/DE60239622D1/de not_active Expired - Lifetime
- 2002-08-16 WO PCT/JP2002/008331 patent/WO2003016906A1/ja active IP Right Grant
-
2005
- 2005-06-22 US US11/157,947 patent/US7435551B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2459489C (en) | 2010-02-02 |
| ATE504001T1 (de) | 2011-04-15 |
| US20050048565A1 (en) | 2005-03-03 |
| ES2361663T3 (es) | 2011-06-21 |
| US20050266506A1 (en) | 2005-12-01 |
| DK1426764T3 (da) | 2011-06-27 |
| CA2459489A1 (en) | 2003-02-27 |
| JP3624216B2 (ja) | 2005-03-02 |
| US7435551B2 (en) | 2008-10-14 |
| WO2003016906A1 (fr) | 2003-02-27 |
| EP1426764B1 (de) | 2011-03-30 |
| US7067634B2 (en) | 2006-06-27 |
| JPWO2003016906A1 (ja) | 2004-12-02 |
| AU2002328630B2 (en) | 2005-09-01 |
| EP1426764A4 (de) | 2005-12-14 |
| EP1426764A1 (de) | 2004-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60239622D1 (de) | Verfahren zur diagnose oder überwachung eines fehlers im zuckerstoffwechsel | |
| EP2124053A1 (de) | Verfahren und Gerät zur Erfassung biologischer Informationen und Verfahren und Gerät zur Messung physiologisch aktiver Substanzen | |
| JP7269182B2 (ja) | 心臓トロポニンｉ及び早期バイオマーカーを使用する、ヒト対象における軽度外傷性脳損傷を診断及び査定する一助となるための方法 | |
| US12163958B2 (en) | Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase L1 | |
| ES2474690T3 (es) | Indicador de carga biológica y método de medida de la carga biológica | |
| AU2018378084A1 (en) | Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1 | |
| DK1342794T3 (da) | Fremgangsmåde og anordning til at bestemme vævsspecificitet af fritflydende DNA i legemsvæsker | |
| AU2018272054A1 (en) | Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers | |
| EP2494922A3 (de) | Verarbeitung von Analytsensordaten | |
| HK1113160A1 (en) | Methods for the diagnosis of dementia and other neurological disorders | |
| WO2009132058A3 (en) | Levels of bcma protein expression on b cells and use in diagnostic methods | |
| TW200716981A (en) | Method for the quantitative measurement of analytes in a liquid sample by immunochromatography | |
| WO2010132447A3 (en) | Methods for detecting pre-diabetes and diabetes using differential protein glycosylation | |
| Hampel et al. | Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease | |
| WO2007015113A3 (en) | New protein isoforms of the pif-family and uses thereof | |
| ATE520033T1 (de) | Neurotoxische aminosäure oder neurotoxisches derivat davon in zusammenhang mit neurologischen erkrankungen | |
| US20190041407A1 (en) | Devices, systems and methods for quantifying hemoglobin s concentration | |
| WO2005071407A3 (en) | Methods of diagnosing acute coronary syndrome by measuring urotensin ii | |
| EP3221444A1 (de) | Lateralflussassayverhältnistest | |
| WO2019010131A1 (en) | IMPROVED METHODS FOR MEASURING CARBOXY TERMINATION HYDROLASE LEVELS OF UBIQUITIN L1 IN BLOOD | |
| WO2008035204A3 (en) | Prediction and prophylactic treatment of type 1 diabetes | |
| EP3602069A1 (de) | Verfahren zur unterstützung der diagnose und des ausmasses einer traumatischen hirnverletzung bei einem menschlichen subjekt unter verwendung des frühen carboxyterminalen hydrolasebiomarkers von ubiquitin l1 | |
| ATE421693T1 (de) | Proteine in der diabetes-proteomanalyse | |
| JP2024534849A (ja) | 脳の損傷を診断する方法及びシステム | |
| CN105556306B (zh) | 用于监测多发性硬化(ms)的方法和预后试剂盒 |